LABU vs VIG

ALABU

BVIG

Measures won1–5VIG wins · of 6 · 5Y

$10,000 · 5Y$16,638VIG · SCHD $16,459

Lowest cost0.04%VIG · $4 on $10k

Most income2.96%SCHD · $296 on $10k

Smallest drop−6.9%SCHD · worst fall in 1Y

Held in common1.1%LABU and VIG

LABU

VIG

Direxion Daily S&P Biotech Bull 3X Shares · $567MVanguard Dividend Appreciation ETF · $109B

+61.5%3 years · per year$42,086 · $16,775+18.8%

−26.8%5 years · per year$2,102 · $16,638+10.7%

0.96%Expense ratio$96 · $4 on $10k · lower wins0.04%

0.37%12-mo yield$37 · $146 on $10k1.46%

−41.8%Worst dropSmaller wins−7.9%

89.9%VolatilityLower wins11.0%

1–5VIG wins

$10,000 · 5 yearsAll four, one scale

Shared top holdingsLABU · VIG

0.4%AMGN1.0%

0.4%ABBV2.0%

0.3%GILD0.8%

Held in common1.1%

End-of-day Nov 9, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Four

5Y4 funds

#
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.46%	+2.4%	+14.8%	+17.6%	+18.8%	+10.7%	−7.9%	$109.1B
2	SCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	2.96%	+1.4%	+33.2%	+39.1%	+19.6%	+10.5%	−6.9%	$121.7B
3	ALABU	Direxion Daily S&P Biotech Bull 3X SharesRead Desk	0.96%	0.37%	+9.5%	+53.8%	+107.4%	+61.5%	−26.8%	−41.8%	$567M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.24%	+2.3%	+12.1%	+16.1%	+23.7%	new	−9.7%	$37.8B

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Four

5Y4 funds

#
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.46%	+2.4%	+14.8%	+17.6%	+18.8%	+10.7%	−7.9%	$109.1B
2	SCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	2.96%	+1.4%	+33.2%	+39.1%	+19.6%	+10.5%	−6.9%	$121.7B
3	ALABU	Direxion Daily S&P Biotech Bull 3X SharesRead Desk	0.96%	0.37%	+9.5%	+53.8%	+107.4%	+61.5%	−26.8%	−41.8%	$567M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.24%	+2.3%	+12.1%	+16.1%	+23.7%	new	−9.7%	$37.8B

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

LABU vs VIG

LABU

Direxion Daily S&P Biotech Bull 3X Shares

$2,102

VIG

Vanguard Dividend Appreciation

$16,638

MeasureLABUVIG

Fee0.96%0.04%

Cost on $10k a year$96$4

Yield0.37%1.46%

5 years, per year−26.8%+10.7%

3 years, per year+61.5%+18.8%

Worst drop · 1Y−41.8%−7.9%

Volatility · 1Y89.9%11.0%

5–1measures won
VIG first

1.1%

holdings shared

Nov 9, 2026 · $10,000 five years ago, dividends reinvested

DGRO vs VIG

YTD

iSharesDGRO

+18.8%

VIGVanguard

+14.8%

+18.8%Year to date+14.8%

1.8%Yield1.5%

$45.5BAssets$109B

2–0DGRO wins

End-of-day Nov 9, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.6%

JEPIJ.P. Morgan

+7.5%

+6.6%Year to date+7.5%

12.4%Yield7.9%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 9, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.3%

SPYSPDR

+11.2%

+11.3%Year to date+11.2%

1.0%Yield1.0%

$179BAssets$778B

1–0SPYM wins

End-of-day Nov 9, 2026

Overlap: LABU, VIG, SCHD, CGDV

Today

29.4%most shared, VIG and CGDV

LABUVIGSCHDCGDV

LABU—1.1%0.4%1.0%

VIG1.1%—14.5%29.4%

SCHD0.4%14.5%—5.8%

CGDV1.0%29.4%5.8%—

End-of-day Nov 9, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$290most kept, SCHD

SCHD$296 − $6 = $290

VIG$146 − $4 = $142

CGDV$124 − $33 = $91

LABU$37 − $96 = −$59

KeptFee

End-of-day Nov 9, 2026 · yield in dollars minus the fee